On the other hand, the IDO1 inhibitor methyl-DL-tryptophan has increased the efficacy of paclitaxel in endometrial cancer xenografts [50], suggesting that the inhibition of IDO1 may improve the chemosensitivity. The gene discussed is IDO1; the disease is endometrial cancer.